French Maritime Pine Bark Extract Pycnogenol Dose-Dependently Lowers Glucose in Type 2 Diabetic Patients

Liu, Ximing; Zhou, Ha-Jun; Rohdewald, Peter
March 2004
Diabetes Care;Mar2004, Vol. 27 Issue 3, p839
Academic Journal
Examines the efficacy of the pycnogenol extracts on patients with type 2 diabetes. Reduction on the glucose level of the patients; Improvement on the quality of life; Assessment on the response of the immune system from the treatment.


Related Articles

  • Is a Long-Term Aerobic Plus Resistance Training Program Feasible for and Effective on Metabolic Profiles in Type 2 Diabetic Patients? Balducci, Stefano; Leonetti, Frida; Di Mario, Umberto; Fallucca, Francesco // Diabetes Care;Mar2004, Vol. 27 Issue 3, p841 

    Examines the significance of aerobic exercise on patients with type 2 diabetes. Decrease of glucose level in the body; Improvement on the quality of life; Reduction on the risks of obesity.

  • Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics' Impaired Healing. Berlanga-Acosta, Jorge; Schultz, Gregory S.; López-Mola, Ernesto; Guillen-Nieto, Gerardo; García-Siverio, Marianela; Herrera-Martínez, Luis // BioMed Research International;2013, p1 

    Type 2 diabetes mellitus is a metabolic noncommunicable disease with an expanding pandemic magnitude. Diabetes predisposes to lower extremities ulceration and impairs the healing process leading to wound chronification. Diabetes also dismantles innate immunity favoring wound infection....

  • Erectile Dysfunction and Quality of Life in Type 2 Diabetic Patients. De Berardis, Giorgia; Franciosi, Monica; Belfiglio, Maurizio; Di Nardo, Barbara; Pellegrini, Fabio; Sacco, Michele; Tognoni, Gianni; Valentini, Miriam; Nicolucci, Antonio; Greenfield, Sheldon; Kaplan, Sherrie H. // Diabetes Care;Feb2002, Vol. 25 Issue 2, p284 

    Provides information on a study which assessed the prevalence of self-reported erectile dysfunction (ED) and evaluated its impact on quality of life (QOL) in type 2 diabetic patients. Research design and methods of the study; QOL frequency scale scores according to ED frequency;...

  • Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes. Redekop, W. Ken; Koopmanschap, Marc A.; Niessen, Louis W.; Stolk, Ronald P.; Rutten, Guy E. H. M.; Wolffenbuttel, Bruce H. R. // Diabetes Care;Mar2002, Vol. 25 Issue 3, p458 

    Focuses on a study which estimated the health-related quality of life and treatment satisfaction for patients with type 2 diabetes in the Netherlands. Research design and methods; Results; Conclusions.

  • The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus. Gordon, Jason; McEwan, Phil; Hurst, Michael; Puelles, Jorge // Diabetes Therapy;Dec2016, Vol. 7 Issue 4, p825 

    Introduction: ENDURE (ClinicalTrials.gov identifier, NCT00856284), a multicenter, double-blind, active-controlled study of 2639 patients with uncontrolled type 2 diabetes mellitus (T2DM), found that metformin in combination with alogliptin (12.5 and 25 mg doses), when compared to standard add-on...

  • Education improves management of diabetes.  // Research Review (International Council on Active Aging);10/19/2011, Vol. 11 Issue 38, p4 

    The article discusses a research on the benefits of education in helping diabetics effectively manage their disease. In a structured behavior intervention, findings showed that structure, cognitive behavioral program helped type 2 diabetics improve. Those who underwent individual education...

  • Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of Type 2 Diabetic Subjects. Jacob, Stephan; Machann, Jurgen; Rett, Kristian; Brechtel, Klaus; Volk, Annette; Renn, Walter; Maerker, Elke; Matthaei, Stephan; Schick, Fritz; Claussen, Claus-D.; Haring, Hans-Ulrich // Diabetes;May99, Vol. 48 Issue 5, p1113 

    Examines the relation of insulin resistance with intramyocellular lipid content in lean nondiabetic children of type two diabetic subjects. Role of insulin resistance in the development of type two diabetes; Insulin sensitivity and glucose levels of subjects; Association of insulin sensitivity...

  • Pharmacogenetics in Type 2 Diabetes: Polymorphisms in Candidate Genes Affecting Responses to Antidiabetic Oral Treatment. Sesti, G.; Hribal, M. L. // Current Pharmacogenomics;Mar2006, Vol. 4 Issue 1, p69 

    Type 2 diabetes is a complex and heterogeneous metabolic condition that has reached epidemic proportions, affecting more than 150 million individuals worldwide. Maintenance of near-normal glucose control in patients with type 2 diabetes been shown to be associated with a reduced risk of...

  • Controlling Blood Glucose Levels in Patients with Type 2 Diabetes Mellitus. Woolf, Steven H.; Davidson, Mayer B.; Greenfield, Sheldon; Bell, Hanan S.; Ganiats, Theodore G.; Hagen, Michael D.; Palda, Valerie Anne; Rizza, Robert A.; Spann, Stephen J. // Journal of Family Practice;May2000, Vol. 49 Issue 5, p453 

    OBJECTIVE: To review evidence about the benefit of intensive glycemic control for patients with type 2 diabetes and to develop practice recommendations. PARTICIPANTS: A 9-member panel composed of family physicians, general internists, endocrinologists, and a practice guidelines methodologist was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics